Medical Xpess - glutamate ( ... sorted: rank/1w)

The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two ...

Jun 17, 2013

4.9 / 5 (26) |

12 |

Diabetes

Markers of beta-cell dysfunction associated with high rate of progression to type 1 diabetes

The majority of children at risk of type 1 diabetes who developed 2 or more diabetes-related autoantibodies developed type 1 diabetes within 15 years, findings that highlight the need for research into finding interventions ...

17 hours ago

not rated yet |

News tagged with glutamate

New drug reverses loss of brain connections in Alzheimer's disease

Markers of beta-cell dysfunction associated with high rate of progression to type 1 diabetes